• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Tariol
    / Taro International Ltd


    Active Ingredient *

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Gel

    1 X 30 gr

    הופסק שיווק

    partial basket chart

    Gel

    1 X 60 gr

    partial basket chart

    Dosage

    Should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for “non-scalp” areas. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision.
    When using calcipotriol containing products, the maximum daily dose should not exceed 15 g. The body surface area treated with calcipotriol containing products should not exceed 30%.


    Indications

    Treatment of psoriasis of the scalp and for the treatment of mild to moderate psoriasis vulgaris of other body areas in adults 18 years of age and older.


    Contra-Indications

    * Hypersensitivity to the active substances or to any of the excipients.
    * Patients with known disorders of calcium metabolism.
    * Erythrodermic, exfoliative and pustular psoriasis.
    * Due to the content of corticosteroid, is contraindicated in the following conditions: Viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers, wounds.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Manufacturer
    Taro Pharmaceuticals Inc., Canada
    CLOSE